Relationship of age and exercise performance in patients with heart failure: the HF-ACTION study
- PMID: 19782790
- PMCID: PMC2762946
- DOI: 10.1016/j.ahj.2009.07.018
Relationship of age and exercise performance in patients with heart failure: the HF-ACTION study
Abstract
Background: More than three fourths of patients with heart failure (HF) are 65 years and older, and older age is associated with worse symptoms and prognoses than is younger age. Reduced exercise capacity is a chief HF complaint and indicates poorer prognosis, especially among elderly persons, but the mechanisms underlying functional decline in older patients with HF are largely unknown.
Methods: Baseline cardiopulmonary exercise testing data from the HF-ACTION trial were assessed to clarify age effects on peak oxygen consumption (VO(2)) and ventilation-carbon dioxide production (VE/VCO(2)) slope.
Results: Among 2,331 New York Heart Association class II-IV patients with HF, increased age corresponded to decreased peak VO(2) (-0.14 mL kg(-1) min(-1) per year >40 years; P < .0001) and increased VE/VCO(2) slope (0.30 U/y >70 years; P < .0001). In a multivariable model with 34 other potential determinants, age was the strongest independent predictor of peak VO(2) (partial R(2) 0.130, total R(2) 0.392; P < .001) and a significant but relatively weaker predictor of VE/VCO(2) slope (partial R(2) 0.037, total R(2) 0.199; P < .001). Blunted peak heart rate was also a strong predictor of peak VO(2). Although peak heart rate and age were strongly correlated, both were significant independent predictors of peak VO(2) when analyzed simultaneously in a model. Aggregate comorbidity increased significantly with age but did not account for age effects on peak VO(2).
Conclusions: Age is the strongest predictor of peak VO(2) and a significant predictor of VE/VCO(2) slope in the HF-ACTION population. Age-dependent comorbidities do not explain changes in peak VO(2). Age-related changes in cardiovascular physiology, potentially magnified by the HF disease state, should be considered a contributor to the pathophysiology and a target for more effective therapy in older patients with HF.
Figures




References
-
- Curtis LH, Whellan DJ, Hammill BG, et al. Incidence and prevalence of heart failure in elderly persons, 1994–2003. Arch Intern Med. 2008;168:418–24. - PubMed
-
- Kannel WB. Incidence and epidemiology of heart failure. Heart Fail Rev. 2000;5:167–73. - PubMed
-
- Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation. 2003;107:346–54. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 HL064257/HL/NHLBI NIH HHS/United States
- 5U01HL064264/HL/NHLBI NIH HHS/United States
- U01 HL064250/HL/NHLBI NIH HHS/United States
- P60AG10484/AG/NIA NIH HHS/United States
- R01 AG018915/AG/NIA NIH HHS/United States
- U01 HL064265/HL/NHLBI NIH HHS/United States
- U01 HL066497/HL/NHLBI NIH HHS/United States
- U01 HL064264/HL/NHLBI NIH HHS/United States
- 5U01HL066482/HL/NHLBI NIH HHS/United States
- 5U01HL066497/HL/NHLBI NIH HHS/United States
- U01 HL068980/HL/NHLBI NIH HHS/United States
- 5U01HL064250/HL/NHLBI NIH HHS/United States
- 5U01HL064265/HL/NHLBI NIH HHS/United States
- U01 HL066491/HL/NHLBI NIH HHS/United States
- 5U01HL068973/HL/NHLBI NIH HHS/United States
- 5U01HL064257/HL/NHLBI NIH HHS/United States
- U01 HL066482/HL/NHLBI NIH HHS/United States
- 5U01HL063747/HL/NHLBI NIH HHS/United States
- 5U01HL066491/HL/NHLBI NIH HHS/United States
- R37AG18915/AG/NIA NIH HHS/United States
- R37 AG018915/AG/NIA NIH HHS/United States
- U01 HL066494/HL/NHLBI NIH HHS/United States
- 5U01HL066501/HL/NHLBI NIH HHS/United States
- U01 HL068973/HL/NHLBI NIH HHS/United States
- 5U01HL068980/HL/NHLBI NIH HHS/United States
- U01 HL063747/HL/NHLBI NIH HHS/United States
- 5U01HL066494/HL/NHLBI NIH HHS/United States
- U01 HL066501/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous